Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2918744

Cl.Fc1ccc2c(c1)CC(c1c[nH]cn1)C2

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 4/20 0.39
ADRA2A known ✓ P08913 2/20 0.39
ADRA2B known ✓ P18089 2/20 0.39
ADRA2C known ✓ P18825 2/20 0.39
DRD2 known ✓ P14416 3/20 0.35
DRD3 known ✓ P35462 3/20 0.35
HTR1A known ✓ P08908 2/20 0.35
HTR2A known ✓ P28223 2/20 0.35
HTR7 known ✓ P34969 2/20 0.35
HTR2B known ✓ P41595 1/20 0.35
HTR1D known ✓ P28221 1/20 0.34
HTR1B known ✓ P28222 1/20 0.34
CHRNB4 known ✓ P30926 1/20 0.33
CHRNA3 known ✓ P32297 1/20 0.33
CHRNA7 known ✓ P36544 1/20 0.33
DRD4 known ✓ P21917 1/20 0.33
HTR2C known ✓ P28335 1/20 0.33
SIGMAR1 known ✓ Q99720 1/20 0.33
DRD1 known ✓ P21728 1/20 0.32
ADRA1B known ✓ P35368 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL936991 0.98 SLC6A4 (0.40) SLC6A4ADRA2AADRA2BADRA2CDRD2
Hydrochloric Acid SCHEMBL8614363 0.80 ADRA1A (0.43) CHRNB2CHRNA4
SCHEMBL5827303 0.80 PSEN1 (0.32) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL7643514 0.80 SLC6A4 (0.40) SLC6A4DRD2DRD3HTR1AHTR2A
SCHEMBL5827252 0.79 ADRA1A (0.44) CHRNB2CHRNA4
SCHEMBL5827498 0.74 PNMT (0.47) ADRA2AADRA2BADRA2C
SCHEMBL7644557 0.72 DRD2 (0.39) ADRA2ADRD2DRD3HTR1AHTR7
SCHEMBL14261202 0.72 CYP3A4 (0.43) SLC6A4ADRA2AHTR2BHTR2CSRD5A1
SCHEMBL5827464 0.71 GRIN2B (0.35) DRD2DRD3HTR1DHTR1BPSEN1
Hydrochloric Acid SCHEMBL5827405 0.69 POLB (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897166-B1 Biodegradable ceramic fibres from silica sols DELSITECH OY (FI) 2011-03-01 US disclosed
EP-1372727-B1 BIODEGRADABLE CARRIER AND METHOD FOR PREPARATION THEREOF DELSITECH OY (FI) 2010-09-01 EP disclosed
US-7727543-B2 Biodegradable carrier and method for preparation thereof DELSITECH OY (FI) 2010-06-01 US disclosed
US-20090104245-A1 BIODEGRADABLE CARRIER AND METHOD FOR PREPARATION THEREOF KOSKINEN MIKA 2009-04-23 US disclosed
EP-0906243-B2 DISSOLVABLE OXIDES FOR BIOLOGICAL APPLICATIONS DELSITECH OY (FI) 2009-04-01 EP disclosed
US-7485318-B2 makes it possible to add viruses as biologically active agents into a biodegradable gel so that viruses do not loose their activity to infect and/or transfect cells DELSITECH OY (FI) 2009-02-03 US disclosed
US-7326422-B2 Dissolvable oxides for biological applications DELSITECH OY (FI) 2008-02-05 US disclosed
EP-1144323-B1 BIODEGRADABLE CERAMIC FIBRES FROM SILICA SOLS DELSITECH OY (FI) 2007-07-25 EP disclosed
EP-1618896-A2 Dissolvable oxides for biological applications Delsitech OY (FI) 2006-01-25 EP disclosed
EP-0906243-B1 DISSOLVABLE OXIDES FOR BIOLOGICAL APPLICATIONS DELSITECH OY (FI) 2005-08-03 EP disclosed
US-6764690-B2 DRUG DELIVERY DELSITECH OY (FI) 2004-07-20 US disclosed
US-20040121451-A1 Treatment of sols, gels and mixtures thereof DELSITECH OY (FI) 2004-06-24 US disclosed
US-20040120971-A1 Biodegradable carrier and method for preparation thereof DELSITECH OY (FI) 2004-06-24 US disclosed
EP-1368071-A1 TREATMENT OF SOLS, GELS, MIXTURES OR COMPOSITES OF SOLS AND GELS, AND/OR SOL-GEL DERIVED MATERIALS Delsitech OY (FI) 2003-12-10 EP disclosed
CN-1103320-C Delivery system for the controlled release of biologically active agents, pharmaceutical products containing it and uses thereof BICSID OY (FI) 2003-03-19 CN disclosed
US-20030021820-A1 Dissolvable oxides for biological applications BIOXID OY 2003-01-30 US disclosed
WO-2002074354-A1 TREATMENT OF SOLS, GELS, MIXTURES OR COMPOSITES OF SOLS AND GELS, AND/OR SOL-GEL DERIVED MATERIALS DELSITECH OY (FI) 2002-09-26 WO disclosed
CN-1219919-A Soluble oxides for biological applications ORION YHTYM OY (FI) 1999-06-16 CN disclosed
EP-0906243-A1 DISSOLVABLE OXIDES FOR BIOLOGICAL APPLICATIONS ORION CORPORATION (ORION-YHTYMA OY) (FI) 1999-04-07 EP disclosed
WO-1997045367-A1 DISSOLVABLE OXIDES FOR BIOLOGICAL APPLICATIONS Orion-Yhtymä Oy (FI) 1997-12-04 WO disclosed